Insider · CIK 0001857905
Corleen M. Roche
Files at IOVA (IOVANCE BIOTHERAPEUTICS, INC.), CGON (CG Oncology, Inc.). First filing Jan 31, 2024, latest Jan 31, 2024.
In brief
Corleen M. Roche files SEC Form 4 as CFO at CGON (CG Oncology, Inc.), and also at IOVA (IOVANCE BIOTHERAPEUTICS, INC.). Since Jan 31, 2024, Corleen M. Roche has reported 1 open-market buy worth $38k and 0 open-market sells worth $0, the latest filed on Jan 31, 2024.
A track record needs three past buys with six months of prices behind them; Corleen M. Roche has 0, so none is measured yet.
The newest scored trade: bought $38k of CGON on Jan 29, 2024, filed Jan 31, 2024, scored 61 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CGON: CG Oncology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | CG Oncology, Inc. | $38k 2,000 shares | - | +6% from low-0% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | MOption exercise Common Stock | +49,995 | $0.00 | $0 | 49,995 | Aug 10, 2026 |
| Aug 6, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | FTax withholding Common Stock | -21,238 | $6.21 | $132k | 28,757 | Aug 10, 2026 |
| Aug 6, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -49,995 | $0.00 | $0 | 100,005 | Aug 10, 2026 |
| Mar 9, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Restricted Stock Unitsderivative | +132,200 | $0.00 | $0 | 132,200 | Mar 11, 2026 |
| Aug 6, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Aug 8, 2025 |
| Aug 6, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Restricted Stock Unitsderivative | +150,000 | $0.00 | $0 | 150,000 | Aug 8, 2025 |
| Apr 15, 2025 | CGON CG Oncology, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +143,907 | $0.00 | $0 | 143,907 | Apr 16, 2025 |
| Jan 29, 2024 | CGON CG Oncology, Inc. | POpen-market purchase Common Stock | +2,000 | $19.00 | $38k | 2,000 | Jan 31, 2024 |
| Jan 24, 2024 | CGON CG Oncology, Inc. | AGrant or award Stock Optionderivative | +492,920 | $0.00 | $0 | 492,920 | Jan 26, 2024 |
Questions about Corleen M. Roche
Answered from the filings on this page, as of the latest one.
Is Corleen M. Roche buying or selling?
Not in the last 12 months. Corleen M. Roche's latest open-market trade on SEC Form 4 was bought $38k of CGON on Jan 29, 2024.
How did Corleen M. Roche's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Corleen M. Roche has 0.
Where does Corleen M. Roche file Form 4?
Corleen M. Roche has filed Form 4 at CGON (CG Oncology, Inc.) as CFO & Secretary; IOVA (IOVANCE BIOTHERAPEUTICS, INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.